Arkis BioSciences

Arkis offers groundbreaking neurosurgical treatments for intracranial hypertension including hydrocephalus, traumatic brain injury, stroke, & similar disorders.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Knoxville, TN, US
  • Currency USD
  • Founded February 2011
  • Employees 11
  • Incorporation Type C-corp
  • Website arkisbiosciences.com

Company Summary

Arkis BioSciences develops, markets, and sells advanced catheters and minimally invasive instrumentation for neurosurgery. Arkis' proprietary catheters incorporate Endexo, intended to reduce catheter related complications, while the company's instrumentation is designed to be less invasive over a variety of neurosurgical procedures. Altogether, the company's portfolio enables healthcare practitioners the potential to reduce surgical trauma, shorten surgical duration, and reduce treatment complications.

Team

  • Chad Seaver, Ph.D.
    Chief Executive Officer

    Chief Executive of Arkis BioSciences with over twenty years’ experience leading the development and commercialization of new medical devices with startups leading to IPO’s to acquisitions by global healthcare conglomerates. Strong background in business development, staff management, project leadership, and new product introductions, spanning R&D through customer development.

  • James Killeffer
    Chief Medical Officer

    Chief Medical Officer of Arkis BioSciences with eighteen years neurosurgical practice at the University of Tennessee Medical Center. Researcher of traumatic brain injury and hydrocephalus. President of University Neurosurgery P.C. and Chief of the Division of Neurosurgery and Assistant Professor of the University of Tennessee’s Graduate School of Medicine.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free